The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Cyclo‐oxygenase‐2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
Open accessAbstract
Cyclo‐oxygenase is expressed in cells in two distinct isoforms. Cyclo‐oxygenase‐1 is present constitutively whilst cyclo‐oxygenase‐2 is expressed primarily after inflammatory insult. The activity of cyclo‐oxygenase‐1 and ‐2 results in the production of a variety of potent biological mediators (the prostaglandins) that regulate homeostatic and disease processes. Inhibitors of cyclo‐oxygenase include the nonsteroidal anti‐inflammatory drugs (NSAIDs) aspirin, ibuprofen and diclofenac. NSAIDs inhibit cyclo‐oxygenase‐2 at the site of inflammation, to produce their therapeutic benefits, as well as cyclo‐oxygenase‐1 in the gastric mucosa, which produces gastric damage. Most recently selective inhibitors of cyclo‐oxygenase‐2 have been developed and introduced to man for the treatment of arthritis. Moreover, recent epidemiological evidence suggests that cyclo‐oxygenase inhibitors may have important therapeutic relevance in the prevention of some cancers or even Alzheimer's disease. This review will discuss how the new advancements in NSAIDs research has led to the development of a new class of NSAIDs that has far reaching implications for the treatment of disease. British Journal of Pharmacology (1999) 128, 1121–1132; doi:10.1038/sj.bjp.0702897
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Moncada, S., Gryglewski, R., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,595
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734
Cyclooxygenase in biology and disease
DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., van de Putte, L. B. A., & Lipsky, P. E. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,506
Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
Kurumbail, R. G., Stevens, A. M., Gierse, J. K., McDonald, J. J., Stegeman, R. A., Pak, J. Y., Gildehaus, D., iyashiro, J. M., Penning, T. D., Seibert, K., et al. (1996) · Nature · doi:10.1038/384644a0 · Cited by 1,917
Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W., & Herschman, H. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98774-0 · Cited by 1,789
Xie, W. L., Chipman, J. G., Robertson, D. L., Erikson, R. L., & Simmons, D. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2692 · Cited by 1,707
Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J., & Vane, J. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11693 · Cited by 1,659
Self-citationWarner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A., & Vane, J. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7563 · Cited by 1,519
Self-citationMcAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1
Picot, D., Loll, P. J., & Garavito, R. M. (1994) · Nature · doi:10.1038/367243a0 · Cited by 1,265
Meade, E. A., Smith, W. L., & DeWitt, D. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53294-4 · Cited by 1,256
Radomski, M. W., Palmer, R. M. J., & Moncada, S. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb11367.x · Cited by 1,164
Risk of Alzheimer's disease and duration of NSAID use
Stewart, W. F., Kawas, C., Corrada, M., & Metter, E. J. (1997) · Neurology · doi:10.1212/wnl.48.3.626 · Cited by 1,132
Aspirin and the Risk of Colorectal Cancer in Women
Giovannucci, E., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331001 · Cited by 1,090
Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.
Vane, J. R., Mitchell, J. A., Appleton, I., Tomlinson, A., Bishop-Bailey, D., Croxtall, J., & Willoughby, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2046 · Cited by 1,033
Self-citationThe induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes.
Fu, J. Y., Masferrer, J. L., Seibert, K., Raz, A., & Needleman, P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44821-6 · Cited by 944
Harris, R. C., McKanna, J. A., Akai, Y., Jacobson, H. R., Dubois, R. N., & Breyer, M. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117620 · Cited by 860
Henry, D., Lim, L. L.-Y., Rodriguez, L. A. G., Gutthann, S. P., Carson, J. L., Griffin, M., Savage, R., Logan, R., Moride, Y., Hawkey, C., et al. (1996) · BMJ · doi:10.1136/bmj.312.7046.1563 · Cited by 827
cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase.
O'Banion, M. K., Winn, V. D., & Young, D. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4888 · Cited by 821
Radomski, M. W., Palmer, R. M. J., & Moncada, S. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb11310.x · Cited by 816
Clària, J., & Serhan, C. N. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9475 · Cited by 700
Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer.
Tucker, O., Dannenberg, A. J., Yang, E. K., Zhang, F., Teng, L., Daly, J. M., Soslow, R. A., Masferrer, J. L., Woerner, B. M., Koki, A. T., et al. (1999) · PubMed · Cited by 692
Cyclooxygenase-2 expression in human esophageal carcinoma.
Zimmermann, K. C., Sarbia, M., Weber, A., Borchard, F., Gabbert, H. E., & Schrör, K. (1999) · PubMed · Cited by 664
Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes.
Miyamoto, T., Ogino, N., Yamamoto, S., & Hayaishi, O. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33534-2 · Cited by 663
Yamamoto, K., Arakawa, T., Ueda, N., & Yamamoto, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31315 · Cited by 647 · cited 3×
“These pathways include, but are not limited to, reactive oxygen intermediates (Feng et al., 1995), NF-kB and NF-IL6 (Yamamoto et al., 1995), Ras/Rac1/ MEKK-1/JNK kinase/JNK signal transduction leading to phosphorylation of c-Jun (Xie & Herschman, 1996), ceramide (Hayakawa et al., 1996), mitogen-activated protein kinas…”
BackgroundMizuno, H., Sakamoto, C., Matsuda, K., Wada, K., Uchida, T., Noguchi, H., Akamatsu, T., & Kasuga, M. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024292 · Cited by 637
Prostaglandin endoperoxide synthase: regulation of enzyme expression
DeWitt, D. L. (1991) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(91)90032-d · Cited by 637
Catella-Lawson, F., McAdam, B., Morrison, B. W., Kapoor, S., Kujubu, D., Antes, L., Lasseter, K. C., Quan, H., Gertz, B. J., & Fitzgerald, G. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38195-9 · Cited by 597
DeWitt, D. L., & Smith, W. L. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1412 · Cited by 596
Anderson, G. D., Hauser, S. D., McGarity, K. L., Bremer, M. E., Isakson, P. C., & Gregory, S. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118717 · Cited by 571
The isoprostanes: Unique bioactive products of lipid peroxidation
Morrow, J. D., & Roberts, L. J. (1997) · Progress in Lipid Research · doi:10.1016/s0163-7827(97)00001-5 · Cited by 557
Cowburn, A. S., Sladek, K., Soja, J., Adamek, L., Nizankowska, E., Szczeklik, A., Lam, B. K., Penrose, J. F., Austen, F. K., Holgate, S. T., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci620 · Cited by 550
Characterization of inducible cyclooxygenase in rat brain
Breder, C. D., Dewitt, D., & Kraig, R. P. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903550208 · Cited by 533
Role of prostaglandin-mediated vasodilatation in inflammation
WILLIAMS, T. J., & PECK, M. J. (1977) · Nature · doi:10.1038/270530a0 · Cited by 515
Fletcher, B. S., Kujubu, D. A., Perrin, D. M., & Herschman, H. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42840-2 · Cited by 491
Feng, L., Xia, Y., Garcia, G. E., Hwang, D., & Wilson, C. B. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117842 · Cited by 479
Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation.
Ristimäki, A., Garfinkel, S., Wessendorf, J., Maciag, T., & Hla, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32638-8 · Cited by 473
Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain
Pasinetti, G. M., & Aisen, P. S. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00218-8 · Cited by 457
Hemler, M., & Lands, W. E. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33098-3 · Cited by 437
Reuter, B. K., Asfaha, S., Buret, A., Sharkey, K. A., & Wallace, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119013 · Cited by 423
Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice.
Masferrer, J. L., Zweifel, B. S., Seibert, K., & Needleman, P. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114850 · Cited by 402
Chan, C.-C., Boyce, S., Brideau, C., Charleson, S., Cromlish, W., Ethier, D., Evans, J., Ford-Hutchinson, A. W., Forrest, M. J., Gauthier, J. Y., et al. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34934-1 · Cited by 398
Molecular mechanisms of diverse actions of prostanoid receptors
Negishi, M., Sugimoto, Y., & Ichikawa, A. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00146-4 · Cited by 387
Amin, A. R., Attur, M., Patel, R. N., Thakker, G. D., Marshall, P. J., Rediske, J., Stuchin, S. A., Patel, I. R., & Abramson, S. B. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119280 · Cited by 385
von Schacky, C., & Weber, P. C. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112261 · Cited by 370
Colorectal Cancer and Nonsteroidal Anti-inflammatory Drugs
Smalley, W. E., & DuBois, R. N. (1997) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60067-8 · Cited by 356
Chakraborty, I., Das, S. K., Wang, J., & Dey, S. K. (1996) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0160107 · Cited by 338
Wallace, J. L., Bak, A., McKnight, W., Asfaha, S., Sharkey, K. A., & MacNaughton, W. K. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70370-1 · Cited by 336
García Rodríguez, L. A., Cattaruzzi, C., Troncon, M. G., & Agostinis, L. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.1.33 · Cited by 335
Spencer, A. G., Woods, J. W., Arakawa, T., Singer, I. I., & Smith, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9886 · Cited by 334
Up‐regulation of cyclooxygenase‐2 mRNA in the rat spinal cord following peripheral inflammation
Beiche, F., Scheuerer, S., Brune, K., Geisslinger, G., & Goppelt-Struebe, M. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00604-7 · Cited by 329
Riendeau, D., Percival, M. D., Boyce, S., Brideau, C., Charleson, S., Cromlish, W., Ethier, D., Evans, J., Falgueyret, J. ‐., Ford‐Hutchinson, A. W., et al. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701076 · Cited by 322
Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects
ROSSAT, J., MAILLARD, M., NUSSBERGER, J., BRUNNER, H., & BURNIER, M. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70056-1 · Cited by 318
Chan, C. C., Boyce, S., Brideau, C., Ford-Hutchinson, A. W., Gordon, R., Guay, D., Hill, R. G., Li, C. S., Mancini, J., & Penneton, M. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10713-1 · Cited by 313
Mitchell, J. A., Belvisi, M. G., Akarasereenont, P., Robbins, R. A., Kwon, O. ‐., Croxtall, J. J., Barnes, P. J., & Vane, J. R. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17093.x · Cited by 307
Self-citationFatty Acid Substrate Specificities of Human Prostaglandin-endoperoxide H Synthase-1 and −2
Laneuville, O., Breuer, D. K., Xu, N., Huang, Z. H., Gage, D. A., Watson, J. T., Lagarde, M., DeWitt, D. L., & Smith, W. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.33.19330 · Cited by 301
Kinetic basis for selective inhibition of cyclo-oxygenases
Gierse, J. K., Koboldt, C. M., Walker, M. C., Seibert, K., & Isakson, P. C. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3390607 · Cited by 287
Klein-Nulend, J., Burger, E. H., Semeins, C. M., Raisz, L. G., & Pilbeam, C. C. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.1.45 · Cited by 285
Murata, H. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00757-6 · Cited by 279
Reginato, M. J., Krakow, S. L., Bailey, S. T., & Lazar, M. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.1855 · Cited by 277
Tazawa, R., Xu, X. M., Wu, K. K., & Wang, L. H. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2167 · Cited by 270
Cylooxygenase-dependent Formation of the Isoprostane, 8-Epi Prostaglandin F2α
Pratico, D., Lawson, J. A., & FitzGerald, G. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.9800 · Cited by 264
Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells.
Sneddon, J. M., & Vane, J. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2800 · Cited by 260
Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide
Hwang, D., Jang, B. C., Yu, G., & Boudreau, M. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00154-8 · Cited by 248
Reddy, S. T., & Herschman, H. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40703-4 · Cited by 244
Aspirin use and potential mechanisms for colorectal cancer prevention.
Williams, C. S., Smalley, W., & DuBois, R. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119651 · Cited by 244
Barry, O. P., Kazanietz, M. G., Praticò, D., & FitzGerald, G. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7545 · Cited by 242
Xie, W., & Herschman, H. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31742 · Cited by 240
MORRISON, B., CHRISTENSEN, S., YUAN, W., BROWN, J., AMLANI, S., & SEIDENBERG, B. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(99)80016-2 · Cited by 233
Perspectives series: cell adhesion in vascular biology. Integrin signaling in vascular biology.
Shattil, S. J., & Ginsberg, M. H. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119500 · Cited by 212
Inducible Cyclooxygenase and Nitric Oxide Synthase
Wu, K. K. (1995) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60669-9 · Cited by 209
Kitamura, Y., Shimohama, S., Koike, H., Kakimura, J.-I., Matsuoka, Y., Nomura, Y., Gebicke-Haerter, P. J., & Taniguchi, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9981 · Cited by 207
Dirig, D. M., Isakson, P. C., & Yaksh, T. L. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37497-x · Cited by 205
The role of IP prostanoid receptors in inflammatory pain
Bley, K. R., Hunter, J. C., Eglen, R. M., & Smith, J. A. M. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(98)01185-7 · Cited by 200
Breder, C. D., & Saper, C. B. (1996) · Brain Research · doi:10.1016/0006-8993(95)01474-8 · Cited by 197
Transcriptional Regulation of Cyclooxygenase-2 in Mouse Skin Carcinoma Cells
Kim, Y., & Fischer, S. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27686 · Cited by 197
Holtzman, M. J., TURK, J. W., & Shornick, L. P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36629-3 · Cited by 188
Willingale, H. L., Gardiner, N. J., McLymont, N., Giblett, S., & Grubb, B. D. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701548 · Cited by 187
Pasinetti, G. M. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981001)54:1<1::aid-jnr1>3.0.co;2-m · Cited by 170
Tocco, G., Freire-Moar, J., Schreiber, S. S., Sakhi, S. H., Aisen, P. S., & Pasinetti, G. M. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6429 · Cited by 170
Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes
Geng, Y., Blanco, F. J., Cornelisson, M., & Lotz, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.2.796 · Cited by 168
Distribution of Cox-1 and Cox-2 in Normal and Inflamed Tissues
Seibert, K., Zhang, Y., Leahy, K., Hauser, S. D., Masferrer, J. L., & Isakson, P. C. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5325-0_24 · Cited by 164
EXPRESSION OF CYCLOOXYGENASE-2 IN HUMAN AND AN ANIMAL MODEL OF RHEUMATOID ARTHRITIS
KANG, R. Y., FREIRE-MOAR, J., SIGAL, E., & CHU, C.-Q. (1996) · Rheumatology · doi:10.1093/rheumatology/35.8.711 · Cited by 161
Sousa, A. R., Pfister, R., Christie, P. E., Lane, S. J., Nasser, S. M., Schmitz-Schumann, M., & Lee, T. H. (1997) · Thorax · doi:10.1136/thx.52.11.940 · Cited by 155
Bazan, N. G., Fletcher, B. S., Herschman, H. R., & Mukherjee, P. K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5252 · Cited by 153
Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells.
Rimarachin, J. A., Jacobson, J. A., Szabo, P., Maclouf, J., Créminon, C., & Weksler, B. B. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.7.1021 · Cited by 153
Identification of a cyclooxygenase-related gene and its potential role in prostaglandin formation
Rosen, G. D., Birkenmeier, T. M., Raz, A., et al. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91819-6 · Cited by 152
Sustained Induction of Prostaglandin Endoperoxide Synthase-2 by Seizures in Hippocampus
Marcheselli, V. L., & Bazan, N. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24794 · Cited by 152
SORLI, C. H., Zhang, H.-J., Armstrong, M. B., Rajotte, R. V., Maclouf, J., & Robertson, R. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1788 · Cited by 150
Renal Identification of Cyclooxygenase-2 in a Subset of Thick Ascending Limb Cells
Vio, C. P., Céspedes, C., Gallardo, P. A., & Masferrer, J. L. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.687 · Cited by 138
Yamamoto, T., & Nozaki‐Taguchi, N. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00817-7 · Cited by 135
DeCaterina, R., Giannessi, D., Mazzone, A., Bernini, W., Lazzerini, G., Maffei, S., Cerri, M., Salvatore, L., & Weksler, B. (1990) · Circulation · doi:10.1161/01.cir.82.2.428 · Cited by 134
Induction of cyclooxygenase-2 mRNA and protein following transient focal ischemia in the rat brain
Planas, A. M., Soriano, M. A., Rodríguez-Farré, E., & Ferrer, I. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12108-g · Cited by 126
Masferrer, J. L., Reddy, S. T., Zweifel, B. S., Seibert, K., Needleman, P., Gilbert, R. S., & Herschman, H. R. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22544-7 · Cited by 125
Constitutive Cyclooxygenase-2 Expression in Healthy Human and Rabbit Gastric Mucosa
Zimmermann, K. C., Sarbia, M., Schrör, K., & Weber, A. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.3.536 · Cited by 121
Dominance of cyclooxygenase-2 in the regulation of pancreatic islet prostaglandin synthesis.
Robertson, R. P. (1998) · Diabetes · doi:10.2337/diabetes.47.9.1379 · Cited by 117
Guo, Q., Wang, L., Ruan, K., & Kulmacz, R. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19134 · Cited by 114
Bishop‐Bailey, D., Larkin, S. W., Warner, T. D., Chen, G., & Mitchell, J. A. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701100 · Cited by 96
Self-citationArmstrong, R. A. (1996) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00103-9 · Cited by 95
Multiple Controls in Inflammation
Cirino, G. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00215-3 · Cited by 94
Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans
Schwartz, J. I., CHAN, C., Mukhopadhyay, S., MCBRIDE, K., JONES, T., Adcock, S., MORITZ, C., Hedges, J. R., Grasing, K., & DOBRATZ, D. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)90087-5 · Cited by 89
Belvisi, M. G., Saunders, M., Yacoub, M. H., & Mitchell, J. A. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702104 · Cited by 87
Self-citationMiller, C. J., Zhang, M., He, Y., Zhao, J., Pelletier, J., Martel‐Pelletier, J., & Battista, J. A. D. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19980615)69:4<392::aid-jcb2>3.0.co;2-i · Cited by 87
Hayakawa, M., Jayadev, S., Tsujimoto, M., Hannun, Y. A., & Ito, F. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0464 · Cited by 87
Cerebromicrovascular Pathology in Alzheimer’s Disease Compared to Normal Aging
de la Torre, J. C. (2009) · Gerontology · doi:10.1159/000213834 · Cited by 86
Constitutive expression of cyclooxygenase-2 in rat vas deferens
McKanna, J. A., Zhang, M., Wang, J., Cheng, H., & Harris, R. C. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.275.1.r227 · Cited by 86
Ukawa, H., Yamakuni, H., Kato, S., & Takeuchi, K. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018846912032 · Cited by 85
Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: What can we expect?
Geis, G. (1999) · Scandinavian Journal of Rheumatology · doi:10.1080/030097499750042407 · Cited by 85
Bishop‐Bailey, D., Pepper, J., Larkin, S. W., & Mitchell, J. A. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.10.1655 · Cited by 83
Self-citationMorisset, S., Patry, C., Lora, M., & de Brum-Fernandes, A. J. (1998) · PubMed · Cited by 82
Purification and Characterization of Recombinant Human Cyclooxygenase-2
Percival, M. D., Ouellet, M., Vincent, C. J., Yergey, J. A., Kennedy, B. P., & O’Neill, G. P. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1478 · Cited by 77
Suppression of principal atherosclerotic mechanisms by prostacyclinc and other eicosanoids
Willis, A. L., Smith, D. L., & Vigo, C. (1986) · Progress in Lipid Research · doi:10.1016/0163-7827(86)90132-3 · Cited by 76
Stroebel, M., & Goppelt‐Struebe, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31602-2 · Cited by 74
Prostanoid receptor heterogeneity through alternative mRNA splicing
Pierce, K. L., & Regan, J. W. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00093-9 · Cited by 74
Selective COX‐2 inhibitors and human inflammatory bowel disease
Mccartney, Mitchell, Fairclough, et al. (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00585.x · Cited by 74
Cyclooxygenase-2 as a therapeutic target
Mitchell, J. A., & Evans, T. W. (1998) · Inflammation Research · doi:10.1007/s000110050287 · Cited by 72
Self-citationBordet, J., Guichardant, M., & Lagarde, M. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90009-4 · Cited by 61
Induction of Cyclooxygenase-2 in Human Saphenous Vein and Internal Mammary Artery
Bishop‐Bailey, D., Pepper, J., Haddad, E. B., Newton, R. C., Larkin, S. W., & Mitchell, J. A. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.9.1644 · Cited by 60
Self-citationSelective Inhibitors of Cyclooxygenase-2: Are They Really Effective, Selective, and GI-safe?
Wallace, J. L., Reuter, B. K., McKnight, W., & Bak, A. (1998) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199800001-00006 · Cited by 58
2,3-Diarylcyclopentenones as Orally Active, Highly Selective Cyclooxygenase-2 Inhibitors
Black, W. C., Brideau, C., Chan, C., Charleson, S. E., Chauret, N., Claveau, D., Ethier, D., Gordon, R. J., Greig, G. M., Guay, J., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980642l · Cited by 57
Jourdan, K. B., Mitchell, J. A., & Evans, T. W. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6523 · Cited by 56
Self-citationHAMILTON, L. C., Mitchell, J. A., Tomlinson, A., & Warner, T. D. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.2.245 · Cited by 55
Self-citationEndothelin-1 induction of cyclooxygenase-2 expression in rat mesangial cells
Hughes, A. K., Padilla, E., Kutchera, W. A., Michael, J. R., & Kohan, D. E. (1995) · Kidney International · doi:10.1038/ki.1995.6 · Cited by 54
The Membrane Association Sequences of the Prostaglandin Endoperoxide Synthases-1 and -2 Isozymes
Li, Y., Smith, T., Grabski, S., & DeWitt, D. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29830 · Cited by 40
Jourdan, K. B., Evans, T. W., Goldstraw, P. G., & Mitchell, J. A. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.9.1025 · Cited by 36
Self-citationSaunders, M. A., Belvisi, M. G., Cirino, G., Barnes, P. J., Warner, T. D., & Mitchell, J. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38062-0 · Cited by 32
Self-citationAssessment of the Therapeutic Use of n-3 Fatty Acids in Vascular Disease and Thrombosis
Goodnight, S. H., Cairns, J. A., Fisher, M., & FitzGerald, G. A. (1992) · CHEST Journal · doi:10.1378/chest.102.4_supplement.374s · Cited by 26
Selective Cyclooxygenase-2 Inhibitors as Potential Therapeutic Agents for Inflammatory Diseases
Chan, C.-C., & Rodger, I. W. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-1813-0_24 · Cited by 10
Cited by
In situ click chemistry generation of cyclooxygenase-2 inhibitors
Bhardwaj, A., Kaur, J., Wuest, M., & Wuest, F. (2017) · Nature Communications · doi:10.1038/s41467-016-0009-6 · Cited by 7,448
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
Warner, T. D., & Mitchell, J. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0645rev · Cited by 614
Self-citationDiclofenac: an update on its mechanism of action and safety profile
Gan, T. J. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.486301 · Cited by 600
Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized
Weder, J. E., Dillon, C. T., Hambley, T. W., Kennedy, B. J., Lay, P. A., Biffin, J. R., Regtop, H. L., & Davies, N. M. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00086-3 · Cited by 536
Phillis, J. W., Horrocks, L. A., & Farooqui, A. A. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.02.002 · Cited by 459
Metadata
- Authors
- Mitchell, J. A., & Warner, T. D.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1999-11
- Volume
- 128
- Issue
- 6
- Pages
- 1121-1132
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1974450761
- Cited by
- 321
- References
- 132
- FWCI
- 10.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.